Please enable Javascript
An official publication of
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Sarah Valentine
Articles by Sarah Valentine
Dual Regimen Shows Promise in Relapsed AML After HSCT
Sarah Valentine
Acute Myeloid Leukemia
|
April 2, 2024
HMA plus venetoclax was found to be effective and well tolerated in patients with AML who relapsed after HSCT.
Read More
Ofatumumab-Based Reduced Intensity Conditioning Lowers GVHD Severity in High-Risk B-Cell Lymphoma
Sarah Valentine
Aggressive B-Cell Lymphoma
|
March 26, 2024
Adding ofatumumab to reduced intensity conditioning is safe and effective in high-risk B-cell non-Hodgkin lymphoma.
Read More